search
Back to results

Neuroimaging Biomarker for Seizures (NIBMSZS)

Primary Purpose

Seizure Disorder, Seizure Disorder, Post Traumatic, Traumatic Brain Injury

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cognitive Behavioral Therapy for Seizures
Standard Medical Care
Sponsored by
Providence VA Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Seizure Disorder focused on measuring Cognitive Behavioral Therapy, Veterans, Quality of Life, Stress Disorders, Post-Traumatic, Convulsion, Non-Epileptic, civilians, healthy volunteers

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Inclusion criteria for PNES, ES and TBI (w/o PNES or ES) participants

    • Individuals with history of documented TBI (any severity).
    • Males and Females ages 18-60 years .
    • Women of child bearing potential, if currently using appropriate contraception.

Inclusion criteria of PNES and ES participants.

  • Diagnosed by video/EEG with lone PNES or by EEG with lone ES.
  • Patients must have at least 1 PNES or 1 ES during the year prior to enrollment.

Exclusion Criteria:

  • Exclusion Criteria of PNES, ES and TBI (w/o PNES or ES) participants

    • Current or past year self-injurious behavior.
    • Current suicidal intent (BDI suicide question 9 score of >1).
    • Current or past year psychosis.
    • Pending litigation or current application for long term disability.
    • Active substance or alcohol use disorder (dependence), per discretion of the investigators.
    • Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at least 30 days prior to study entry.
    • Inability to fill out the self-report surveys.
    • Women who are or/are attempting to become pregnant during the study.
    • Ineligible or unwilling to complete MRI imaging.
    • Inability to document TBI.

Exclusion Criteria for PNES and ES participants

  • Inability or unwillingness to participate in CBT and assigned homework.
  • Currently enrolled in cognitive therapy aimed at PNES (Current CBT or other psychotherapy may be administered).
  • Concurrent mixed ES/PNES or equivocal video/EEG findings in discerning between ES and PNES will not be enrolled.

Sites / Locations

  • University of Alabama at Birmingham
  • Rhode Island Hospital
  • Providence VA Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Active Comparator

Active Comparator

Arm Label

(CBT-Sz) - PNES

(CBT-Sz) - PTE

TBI Control

Healthy Volunteer

Arm Description

Participants with history of a head injury and confirmed Psychogenic Non-Epileptic Seizures will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.

Participants with history of a head injury and confirmed Post-Traumatic Epilepsy (PTE) will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.

Participants with TBI will complete 2 brain fMRI scans.

Healthy control volunteers will complete 2 brain fMRI scans.

Outcomes

Primary Outcome Measures

Number of Epileptic Seizures
epileptic seizure frequency (ES), collected prospectively, using a daily seizure calendar
Number of Nonepileptic Seizures (NES)
psychogenic nonepileptic seizure (NES) frequency, collected prospectively, using a daily seizure calendar
Structural and Functional Neuroimaging
Brain MRI scans

Secondary Outcome Measures

Beck Depression Inventory-II (BDI-II)
The BDI-II assesses depression severity from "0" (no Depression-related symptom) to "3" (severe) on each question. The highest possible score is "51", relating to the worst outcome.
Beck Anxiety Inventory (BAI)
The BDI-II assesses anxiety severity from "0" (no Anxiety-related symptom) to "3" (severe) on each question.
Quality of Life in Epilepsy-31 (QOLIE-31)
his is a 31-item self-report scale used in the seizure population to evaluate Quality of Life. The lowest possible score is 0 and the highest possible score is 100, reflecting a better quality of life.

Full Information

First Posted
December 29, 2017
Last Updated
April 4, 2022
Sponsor
Providence VA Medical Center
Collaborators
University of Alabama at Birmingham, Rhode Island Hospital, Birmingham, Alabama VA Medical Center, United States Department of Defense, Ocean State Research Institute, Inc., Brown University
search

1. Study Identification

Unique Protocol Identification Number
NCT03441867
Brief Title
Neuroimaging Biomarker for Seizures
Acronym
NIBMSZS
Official Title
Neuroimaging Biomarker for Seizures
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 15, 2017 (Actual)
Primary Completion Date
May 15, 2022 (Anticipated)
Study Completion Date
September 14, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Providence VA Medical Center
Collaborators
University of Alabama at Birmingham, Rhode Island Hospital, Birmingham, Alabama VA Medical Center, United States Department of Defense, Ocean State Research Institute, Inc., Brown University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This multi-site study will examine patients with epilepsy (ES) following head injury [i.e., posttraumatic epilepsy (PTE)] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.
Detailed Description
Numerous Veterans and civilians have seizures, which can be epileptic or nonepileptic in nature. Epileptic seizures are caused by abnormal brain cell firing. Nonepileptic seizures appear similar to epileptic seizures, but are associated with traumatic experiences and underlying psychological stressors. Both types of seizure are common and disabling, and many patients with seizures do not have adequate control resulting in loss of quality of life. In this proposed 3-site study ( Providence, RI and Birmingham, AL), which are epilepsy centers with expertise both in epilepsy and psychogenic nonepileptic seizures (PNES), we will enroll 88 patients with video-EEG confirmed PNES and 88 with confirmed post-traumatic epilepsy (PTE) and will obtain functional neuroimaging before and after they receive a behavioral treatment - Cognitive Behavioral Therapy for Seizures. The functional neuroimaging studies in these patients will be compared to patients with traumatic brain injury without seizures to test the hypothesis that the faulty processing of emotions and stress in patients with PNES/PTE and abnormal brain connectivity have unique signals in patients with seizures compared to Veterans without seizures and that the neuroimaging signatures can be modified using behavioral intervention. Impact: This grant application for the first study investigating mechanisms of PNES and PTE will provide increased understanding of neural circuitry in PTE and PNES, which can inform PTE and PNES treatments and could change clinical neurologic and psychiatric practice for PTE and PNES. Participants will be recruited at the Providence VA Medical Center, Rhode Island Hospital, and University of Alabama, Birmingham (UAB).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Seizure Disorder, Seizure Disorder, Post Traumatic, Traumatic Brain Injury, Non-Epileptic Seizure, Conversion Disorder, Magnetic Resonance Imaging, Head Injury, Epilepsy
Keywords
Cognitive Behavioral Therapy, Veterans, Quality of Life, Stress Disorders, Post-Traumatic, Convulsion, Non-Epileptic, civilians, healthy volunteers

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
The neuroimaging analysis will be masked.
Allocation
Non-Randomized
Enrollment
224 (Actual)

8. Arms, Groups, and Interventions

Arm Title
(CBT-Sz) - PNES
Arm Type
Experimental
Arm Description
Participants with history of a head injury and confirmed Psychogenic Non-Epileptic Seizures will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.
Arm Title
(CBT-Sz) - PTE
Arm Type
Experimental
Arm Description
Participants with history of a head injury and confirmed Post-Traumatic Epilepsy (PTE) will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.
Arm Title
TBI Control
Arm Type
Active Comparator
Arm Description
Participants with TBI will complete 2 brain fMRI scans.
Arm Title
Healthy Volunteer
Arm Type
Active Comparator
Arm Description
Healthy control volunteers will complete 2 brain fMRI scans.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Behavioral Therapy for Seizures
Other Intervention Name(s)
Cognitive Behavioral Therapy (CBT-Sz), (CBT-Sz) - PNES, (CBT-Sz) - PTE
Intervention Description
CBT-informed psychotherapy for patients with PNES and PTE
Intervention Type
Other
Intervention Name(s)
Standard Medical Care
Other Intervention Name(s)
Treatment as Usual
Intervention Description
Observational - standard medical care
Primary Outcome Measure Information:
Title
Number of Epileptic Seizures
Description
epileptic seizure frequency (ES), collected prospectively, using a daily seizure calendar
Time Frame
Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline
Title
Number of Nonepileptic Seizures (NES)
Description
psychogenic nonepileptic seizure (NES) frequency, collected prospectively, using a daily seizure calendar
Time Frame
Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline
Title
Structural and Functional Neuroimaging
Description
Brain MRI scans
Time Frame
Baseline and week 13
Secondary Outcome Measure Information:
Title
Beck Depression Inventory-II (BDI-II)
Description
The BDI-II assesses depression severity from "0" (no Depression-related symptom) to "3" (severe) on each question. The highest possible score is "51", relating to the worst outcome.
Time Frame
Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline
Title
Beck Anxiety Inventory (BAI)
Description
The BDI-II assesses anxiety severity from "0" (no Anxiety-related symptom) to "3" (severe) on each question.
Time Frame
Baseline, Weeks 6 and 10, 8 months post baseline, 12 months post baseline
Title
Quality of Life in Epilepsy-31 (QOLIE-31)
Description
his is a 31-item self-report scale used in the seizure population to evaluate Quality of Life. The lowest possible score is 0 and the highest possible score is 100, reflecting a better quality of life.
Time Frame
Baseline, Weeks 6 and 10

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Inclusion criteria for PNES, ES and TBI (w/o PNES or ES) participants Individuals with history of documented TBI (any severity). Males and Females ages 18-60 years . Women of child bearing potential, if currently using appropriate contraception. Inclusion criteria of PNES and ES participants. Diagnosed by video/EEG with lone PNES or by EEG with lone ES. Patients must have at least 1 PNES or 1 ES during the year prior to enrollment. Exclusion Criteria: Exclusion Criteria of PNES, ES and TBI (w/o PNES or ES) participants Current or past year self-injurious behavior. Current suicidal intent (BDI suicide question 9 score of >1). Current or past year psychosis. Pending litigation or current application for long term disability. Active substance or alcohol use disorder (dependence), per discretion of the investigators. Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at least 30 days prior to study entry. Inability to fill out the self-report surveys. Women who are or/are attempting to become pregnant during the study. Ineligible or unwilling to complete MRI imaging. Inability to document TBI. Exclusion Criteria for PNES and ES participants Inability or unwillingness to participate in CBT and assigned homework. Currently enrolled in cognitive therapy aimed at PNES (Current CBT or other psychotherapy may be administered). Concurrent mixed ES/PNES or equivocal video/EEG findings in discerning between ES and PNES will not be enrolled.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
W. Curt LaFrance, Jr., MD, MPH
Organizational Affiliation
Providence VA Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jerzy Szarflarski, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alabama at Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35294
Country
United States
Facility Name
Rhode Island Hospital
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02903
Country
United States
Facility Name
Providence VA Medical Center
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02908
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24989152
Citation
LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI, Machan JT, Miller I, Szaflarski JP; NES Treatment Trial (NEST-T) Consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014 Sep;71(9):997-1005. doi: 10.1001/jamapsychiatry.2014.817.
Results Reference
background
PubMed Identifier
21893668
Citation
Salinsky M, Spencer D, Boudreau E, Ferguson F. Psychogenic nonepileptic seizures in US veterans. Neurology. 2011 Sep 6;77(10):945-50. doi: 10.1212/WNL.0b013e31822cfc46.
Results Reference
background
PubMed Identifier
19562779
Citation
LaFrance WC Jr, Friedman JH. Cognitive behavioral therapy for psychogenic movement disorder. Mov Disord. 2009 Sep 15;24(12):1856-7. doi: 10.1002/mds.22683. No abstract available. Erratum In: Mov Disord. 2010 Oct 15;25(13):2268.
Results Reference
background
PubMed Identifier
20739647
Citation
LaFrance WC Jr, Keitner GI, Papandonatos GD, Blum AS, Machan JT, Ryan CE, Miller IW. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology. 2010 Sep 28;75(13):1166-73. doi: 10.1212/WNL.0b013e3181f4d5a9. Epub 2010 Aug 25.
Results Reference
background
PubMed Identifier
10775516
Citation
Reiter JM, Andrews DJ. A neurobehavioral approach for treatment of complex partial epilepsy: efficacy. Seizure. 2000 Apr;9(3):198-203. doi: 10.1053/seiz.1999.0374.
Results Reference
background
PubMed Identifier
22056814
Citation
Elsas SM, Gregory WL, White G, Navarro G, Salinsky MC, Andrews DJ. Aura interruption: the Andrews/Reiter behavioral intervention may reduce seizures and improve quality of life - a pilot trial. Epilepsy Behav. 2011 Dec;22(4):765-72. doi: 10.1016/j.yebeh.2011.09.030. Epub 2011 Nov 6.
Results Reference
background
PubMed Identifier
22341960
Citation
Michaelis R, Schonfeld W, Elsas SM. Trigger self-control and seizure arrest in the Andrews/Reiter behavioral approach to epilepsy: a retrospective analysis of seizure frequency. Epilepsy Behav. 2012 Mar;23(3):266-71. doi: 10.1016/j.yebeh.2011.11.023. Epub 2012 Feb 15.
Results Reference
background
PubMed Identifier
25306199
Citation
Allendorfer JB, Szaflarski JP. Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy: response to a biochemical evaluation. Epilepsy Behav. 2014 Dec;41:312-3. doi: 10.1016/j.yebeh.2014.08.018. Epub 2014 Oct 11. No abstract available.
Results Reference
background
PubMed Identifier
11094115
Citation
Szaflarski JP, Ficker DM, Cahill WT, Privitera MD. Four-year incidence of psychogenic nonepileptic seizures in adults in hamilton county, OH. Neurology. 2000 Nov 28;55(10):1561-3. doi: 10.1212/wnl.55.10.1561.
Results Reference
background
PubMed Identifier
19652140
Citation
LaFrance WC Jr, Syc S. Depression and symptoms affect quality of life in psychogenic nonepileptic seizures. Neurology. 2009 Aug 4;73(5):366-71. doi: 10.1212/WNL.0b013e3181b04c83.
Results Reference
background
PubMed Identifier
12558580
Citation
Szaflarski JP, Hughes C, Szaflarski M, Ficker DM, Cahill WT, Li M, Privitera MD. Quality of life in psychogenic nonepileptic seizures. Epilepsia. 2003 Feb;44(2):236-42. doi: 10.1046/j.1528-1157.2003.35302.x.
Results Reference
background
PubMed Identifier
20371508
Citation
Voon V, Brezing C, Gallea C, Ameli R, Roelofs K, LaFrance WC Jr, Hallett M. Emotional stimuli and motor conversion disorder. Brain. 2010 May;133(Pt 5):1526-36. doi: 10.1093/brain/awq054. Epub 2010 Apr 5.
Results Reference
background

Learn more about this trial

Neuroimaging Biomarker for Seizures

We'll reach out to this number within 24 hrs